Private Equity

Staff Writer

Guest column: Don’t fear the bubble

VCs should embrace transparency and liquidity much like public companies

3 min read · 25 June 2015

Dashboard: Unicorn fundraising lifts deal total

While deal value in May climbed thanks to Uber and Snapchat, fundraising, M&A and IPOs declined in proceeds

2 min read · 24 June 2015

Breaking through the ice: How Canada’s narwhal club was born

Canada has four companies that have achieved billion-dollar valuations, and many more are nearing the list

5 min read · 18 June 2015

Canada's Genesys leverages strong exit multiples in launch of C$150 mln fund

Toronto-based Genesys Capital focuses on early-stage healthcare and biotech companies

3 min read · 15 June 2015

IPO Profile: OpGen Inc

The life sciences company, backed by Versant and Highland, raised $17.1 million in its IPO

1 min read · 01 June 2015

IPO Profile: Arcadia Biosciences Inc

The biotech company raised nearly $66 million in its offering

1 min read · 01 June 2015

IPO Profile: aTyr Pharma Inc

The biotherapeutics company held a $75 million IPO

2 min read · 01 June 2015

IPO Profile: Collegium Pharmaceutical Inc

The pharmaceutical company raised nearly $70 million in its IPO

1 min read · 01 June 2015

IPO Profile: CoLucid Pharmaceuticals Inc

The biopharmaceutical company raised $55 million in its IPO

1 min read · 01 June 2015

IPO Profile: Adaptimmune Therapeutics PLC

The U.K.-based biotech company was backed by NEA and OrbiMed, among others

2 min read · 01 June 2015

Showing 51 to 60 of 5,637 results
1…57…564